fluoxymesterone and Lymph Node Metastasis

fluoxymesterone has been researched along with Lymph Node Metastasis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miura, S; Yoshida, M1
Abeloff, MD; Falkson, G; Falkson, HC; Gilchrist, K; Gray, R; Tormey, DC1
Allen, S; Bosworth, H; Budman, D; Lehrman, D; Lichtman, SM; Schulman, P; Vinciguerra, V; Weiselberg, L; Weiss, R1

Trials

2 trial(s) available for fluoxymesterone and Lymph Node Metastasis

ArticleYear
[Internal endocrine therapy of breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:5

    Topics: Androstanols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Diethylstilbestrol; Double-Blind Method; Female; Fluoxymesterone; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Testosterone

1984
Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1993, Volume: 127

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Fluoxymesterone; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Receptors, Estrogen; Survival Rate; Tamoxifen; Thiotepa; Vinblastine

1993

Other Studies

1 other study(ies) available for fluoxymesterone and Lymph Node Metastasis

ArticleYear
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
    American journal of clinical oncology, 1991, Volume: 14, Issue:4

    Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esthetics; Female; Fluorouracil; Fluoxymesterone; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prednisone; Radiotherapy; Survival Rate; Thiotepa; Vinblastine; Vincristine

1991